Functional and Survival Outcomes of Partial Versus Radical Nephrectomy in Renal Cell Carcinoma Patients With Pre-Existing Chronic Kidney Disease: A Real-World Study
Luan Kinh Thai, Viet Quang Luu, Sam Minh Thai

TL;DR
This study compares kidney function and survival outcomes in patients with kidney disease who had partial or radical kidney removal for cancer, finding that partial removal better preserves kidney function.
Contribution
The study introduces a proteinuria-driven risk stratification approach to guide surgical decisions in RCC patients with compromised renal function.
Findings
Partial nephrectomy (PN) preserved kidney function better than radical nephrectomy (RN), with smaller eGFR decline and less CKD progression.
Long-term survival outcomes were comparable between PN and RN groups.
Pre-operative proteinuria was identified as a strong predictor of mortality and a key factor in recommending PN.
Abstract
Managing renal cell carcinoma (RCC) in patients with pre-existing chronic kidney disease (CKD) or a solitary kidney requires balancing oncologic control with maximal renal functional preservation. This study analyzes long-term renal function, survival, and complications between partial nephrectomy (PN) and radical nephrectomy (RN) in this high-risk Vietnamese cohort. We retrospectively reviewed 90 patients with RCC and reduced pre-operative estimated glomerular filtration rate (eGFR, < 60 mL/min/1.73 m2) or a solitary kidney who underwent surgery at Cho Ray Hospital between 2019 and 2024. Outcomes included changes in eGFR, CKD stage progression, overall survival (OS), cancer-free survival (CFS), and dialysis-free survival (DFS). Forty-one patients underwent RN and 49 PN. RN cases had significantly larger tumors and higher RENAL complexity scores (P < 0.001). At a mean follow-up of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal cell carcinoma treatment · Multiple and Secondary Primary Cancers · Bladder and Urothelial Cancer Treatments
